Iron overload: An accelerator of deadly cell responses in stroke
A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...
Zacks.com on MSN5h
Roche Gets FDA Approval for Acute Ischemic Stroke Drug for Adults
Roche’s RHHBY member company, Genentech, announced the FDA approval of TNKase (tenecteplase), a thrombolytic or ...
Discovery of growth factor and receptor mechanism in brain could improve stroke care
Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
News Medical9h
Research identifies iron as crucial driver of stroke-related cell death processes
Ischemic stroke continues to rank among the top causes of death and long-term disability globally. While advances in acute treatments like clot retrieval and thrombolysis have improved outcomes, the ...
BioSpace12h
Roche Continues Regulatory Run With Acute Stroke Expansion for Heart Attack Drug
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...